Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Hard Copy Electronic Site License Cardiac Markers - Making their Mark on the Medicines Market Datamonitor, Jan 2002   Description     Table of Contents        Enquire before Buying    Send to a Friend   This brief sets out to: * Review the available diagnostic markers for cardiac ischemia, atherosclerotic disease, heart failure, and platelet function. The four classes of cardiac markers are presented in order of their respective market size, with ischemia markers representing the largest market, and markers of platelet function the smallest. * Analyze each class of marker with respect to accuracy, convenience, usefulness, cost, and inherent shortcomings and/or limitations, and provide a rating for each class based on these parameters * consider the commercial implications of each class of cardiac marker, including the likely impact(s) on the existing CV diagnostics and therapeutics markets * discuss the future role of genetic analysis in shaping the diagnostics and therapeutics markets, with attention paid to genetic markers currently under investigation. Customers who bought this item also bought Emerging CV Market: Cell Transplant Therapies - The End of the Beginning Treatment Algorithms 2001: Schizophrenia - The Rise of Atypical Neuroleptics as the Physicians� Favorite Treatment Algorithms 2002: Alzheimer's Disease - Aricept: the physicians choice Strategic Perspectives 2002: Endometriosis Stakeholder Opinions: HIV Vaccines - The Emperor Has No Clothes Strastegic Perspectives 2001: Diabetic Hypertension - Towards Aggressive, Individual and Holistic Treatment Strategies HIV Update 2001 (3) - The impact of resistance testing Market Dynamics 2001: Anti-hypertensives - Aiirbs battle for supremacy Drugs of Tomorrow 2001: Neuroprotection - Future Strategies for Success Drugs of Tomorrow: Anti-asthmatics - Enter the mAbs Drugs, Devices and Procedures of Tomorrow: Acute Stroke - Chasing the need for speed Cardiac Marker Diagnostic Testing Markets

		Top of page

All rights reserved. � Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster